These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15229275)

  • 1. Treatment of age-related macular degeneration.
    Boase DL
    J R Soc Med; 2004 Jul; 97(7):360; author reply 360. PubMed ID: 15229275
    [No Abstract]   [Full Text] [Related]  

  • 2. Color Doppler imaging of ocular blood flow after combined photodynamic therapy with intravitreal triamcinolone in age-related macular degeneration.
    Cekiç O; Bardak Y; Yeşildağ A
    Curr Eye Res; 2011 Feb; 36(2):149-53. PubMed ID: 21158585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Color Doppler imaging of the retrobulbar circulation in non-exudative and exudative age-related macular degeneration].
    Nowak I; Gajewicz W; Stefańczyk L; Omulecki W
    Klin Oczna; 2005; 107(1-3):63-7. PubMed ID: 16052804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Age-related macular degeneration].
    Naeser K
    Ugeskr Laeger; 2006 Aug; 168(35):2927; author reply 2927. PubMed ID: 16989015
    [No Abstract]   [Full Text] [Related]  

  • 5. [Photodynamic therapy in age-related macular degeneration].
    Yassur Y; Weinberger D; Goldstein M; Loewenstein A
    Harefuah; 2000 Sep; 139(5-6):220-3. PubMed ID: 11062957
    [No Abstract]   [Full Text] [Related]  

  • 6. [Photodynamic therapy for age-related macular degeneration].
    Gomi F
    Nippon Ganka Gakkai Zasshi; 2006 Sep; 110(9):681-2. PubMed ID: 17025222
    [No Abstract]   [Full Text] [Related]  

  • 7. [Photodynamic therapy for age-related macular degeneration in Japanese patients].
    Iida T
    Nippon Ganka Gakkai Zasshi; 2008 Oct; 112(10):843-5. PubMed ID: 18949908
    [No Abstract]   [Full Text] [Related]  

  • 8. Color Doppler imaging discloses reduced ocular blood flow velocities in nonexudative age-related macular degeneration.
    Ciulla TA; Harris A; Chung HS; Danis RP; Kagemann L; McNulty L; Pratt LM; Martin BJ
    Am J Ophthalmol; 1999 Jul; 128(1):75-80. PubMed ID: 10482097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photodynamic therapy for age-related macular degeneration.
    Sivaprasad S; Hammond CJ; Jackson H
    Eye (Lond); 2005 Sep; 19(9):1027-8. PubMed ID: 15467697
    [No Abstract]   [Full Text] [Related]  

  • 10. [Photodynamic therapy of senile macular degeneration].
    Naeser K
    Ugeskr Laeger; 2005 Apr; 167(14):1540-1; author reply 1541. PubMed ID: 15887755
    [No Abstract]   [Full Text] [Related]  

  • 11. Photodynamic therapy for age-related macular degeneration: a candid appraisal.
    Sternberg P; Lewis H
    Am J Ophthalmol; 2004 Mar; 137(3):483-5. PubMed ID: 15013872
    [No Abstract]   [Full Text] [Related]  

  • 12. Help for macular degeneration.
    McDonald HR
    Health News; 1999 Dec; 5(15):1-2. PubMed ID: 10633581
    [No Abstract]   [Full Text] [Related]  

  • 13. Photodynamic therapy for age-related macular degeneration.
    Beck RW
    Am J Ophthalmol; 2004 Sep; 138(3):513; author reply 513-4. PubMed ID: 15364257
    [No Abstract]   [Full Text] [Related]  

  • 14. Using light to treat age-related macular degeneration.
    Nosek J
    Nurs Times; 2005 Nov 15-21; 101(46):30-3. PubMed ID: 16315801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosing regimen and the frequency of macular hemorrhages in neovascular age-related macular degeneration treated with ranibizumab.
    Barbazetto I; Saroj N; Shapiro H; Wong P; Freund KB
    Retina; 2010 Oct; 30(9):1376-85. PubMed ID: 20683380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Improved therapeutic possibilities of age-related macular degeneration. The Danish Society of Ophthalmology].
    Hansen MH; Mortensen KK; Sjølie AK
    Ugeskr Laeger; 2003 Mar; 165(12):1249. PubMed ID: 12701299
    [No Abstract]   [Full Text] [Related]  

  • 17. Photodynamic therapy for age-related macular degeneration.
    Franks W
    Age Ageing; 2002 Jan; 31(1):5-6. PubMed ID: 11850299
    [No Abstract]   [Full Text] [Related]  

  • 18. Risks of adverse events with therapies for age-related macular degeneration: a response.
    Williams T; Reeves BC; Foss AJ; Fell G
    Arch Ophthalmol; 2012 Jan; 130(1):124-5; author reply 125-6. PubMed ID: 22232487
    [No Abstract]   [Full Text] [Related]  

  • 19. Photodynamic therapy with verteporfin is effective for selected patients with neovascular age-related macular degeneration.
    Fine SL
    Arch Ophthalmol; 1999 Oct; 117(10):1400-2. PubMed ID: 10532450
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of intravitreal bevacizumab (Avastin) therapy on retrobulbar blood flow parameters in patients with neovascular age-related macular degeneration.
    Mete A; Saygili O; Mete A; Bayram M; Bekir N
    J Clin Ultrasound; 2010 Feb; 38(2):66-70. PubMed ID: 19953626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.